Company / Gross Profit
Silo Pharma, Inc. Gross Profit History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$66.3K
FY2025
5-year range
$13.2K / $66.3K
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$66,264 in FY2025 with a 5-year CAGR of +38.1%.
Remained stable around $66,264 over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +38.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +38.1%, indicating consistent growth.
- In FY2025, gross profit increased 0.0% year-over-year.
- Lowest gross profit in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $66.3K | +0.0% |
| FY2024 | $66.3K | +0.0% |
| FY2023 | $66.3K | +402.7% |
| FY2020 | $13.2K | +0.0% |
| FY2019 | $13.2K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026